Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luvometinib real-world study in pediatric NF1-associated plexiform neurofibromas (China)
ChiCTR2500115360Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of luvometinib in plexiform neurofibroma (PN), sponsored by Shanghai Ninth People's Hospital. Primary endpoints: Objective response rate, Disease control rate and 7 more. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
luvometinib
03
Conditions
plexiform neurofibroma (PN)
Beyond the preview
Go deeper on ChiCTR2500115360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115360.